Artificial intelligence suitable for blood analysis
The challenges we face
In the dynamic world of medical technology, where innovation meets critical healthcare needs, a breakthrough was on the horizon. The challenge at hand was formidable: to introduce an artificial intelligence solution suitable for blood analysis into the medical market. This venture was not just about technological advancement but also about navigating the complex landscape of medical regulations, ensuring long-term availability, and achieving cost-effectiveness, especially for local clinics and laboratories in developing countries.
Amirai, known for its pioneering spirit in the realm of technology, took on this challenge with a strategic approach. Understanding the multifaceted needs of the market, Amirai embarked on a mission to support the customer's journey from concept to compliance. The focal point of this endeavor was the selection and partial redesign of one of Amirai's ARM-based Single Board Computers (SBCs), which stood out for its compatibility with CE medical regulations.
What we do
The journey through certification was a collaborative effort, guided by Amirai's Validation & Verification department. This partnership was instrumental in navigating the intricacies of medical compliance, providing all necessary pre-compliance information, and ensuring that the equipment met the stringent standards required for medical use.
The achievement of Amirai in this project goes beyond the technical specifications. It lies in the ability to offer cost-effective solutions that do not compromise on quality or compliance, coupled with the agility to respond swiftly to customer needs and adapt designs to meet certification requirements. This endeavor not only marked a significant milestone in bringing AI-driven blood analysis to the forefront of medical technology but also demonstrated Amirai's commitment to empowering healthcare providers in developing countries with affordable, high-quality diagnostic tools.